nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Fluocinolone Acetonide—atopic dermatitis	0.687	1	CbGbCtD
Epirubicin—AURKA—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000865	0.144	CbGdCrCtD
Epirubicin—AURKA—Sirolimus—Pimecrolimus—atopic dermatitis	0.000865	0.144	CbGdCrCtD
Epirubicin—AURKA—Temsirolimus—Tacrolimus—atopic dermatitis	0.000865	0.144	CbGdCrCtD
Epirubicin—AURKA—Sirolimus—Tacrolimus—atopic dermatitis	0.000865	0.144	CbGdCrCtD
Epirubicin—PLA2G4A—Carbinoxamine—Diphenhydramine—atopic dermatitis	0.00028	0.0464	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Desonide—atopic dermatitis	0.000191	0.0317	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Desonide—atopic dermatitis	0.000191	0.0317	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Fluocinonide—atopic dermatitis	0.000153	0.0254	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Fluocinonide—atopic dermatitis	0.000153	0.0254	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000149	0.0247	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000149	0.0247	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Mometasone—atopic dermatitis	0.000119	0.0197	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Mometasone—atopic dermatitis	0.000119	0.0197	CbGdCrCtD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CABIN1—atopic dermatitis	7.84e-05	0.07	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Hydrocortisone—atopic dermatitis	7.52e-05	0.0125	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Hydrocortisone—atopic dermatitis	7.52e-05	0.0125	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—atopic dermatitis	7.1e-05	0.0118	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—atopic dermatitis	7.1e-05	0.0118	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—atopic dermatitis	6.99e-05	0.0116	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—atopic dermatitis	6.99e-05	0.0116	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—atopic dermatitis	6.83e-05	0.0113	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—atopic dermatitis	6.83e-05	0.0113	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—atopic dermatitis	6.48e-05	0.0107	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—atopic dermatitis	6.48e-05	0.0107	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—atopic dermatitis	6.32e-05	0.0105	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—atopic dermatitis	6.32e-05	0.0105	CbGdCrCtD
Epirubicin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	6.18e-05	0.000202	CcSEcCtD
Epirubicin—Convulsion—Triamcinolone—atopic dermatitis	6.18e-05	0.000202	CcSEcCtD
Epirubicin—Tachycardia—Prednisolone—atopic dermatitis	6.17e-05	0.000202	CcSEcCtD
Epirubicin—TOP2A—Methyltestosterone—Hydrocortisone—atopic dermatitis	6.17e-05	0.0102	CbGdCrCtD
Epirubicin—Convulsion—Methylprednisolone—atopic dermatitis	6.16e-05	0.000202	CcSEcCtD
Epirubicin—Hypertension—Triamcinolone—atopic dermatitis	6.15e-05	0.000201	CcSEcCtD
Epirubicin—Hypertension—Methylprednisolone—atopic dermatitis	6.14e-05	0.000201	CcSEcCtD
Epirubicin—Infection—Hydrocortisone—atopic dermatitis	6.14e-05	0.000201	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisolone—atopic dermatitis	6.12e-05	0.0002	CcSEcCtD
Epirubicin—Shock—Hydrocortisone—atopic dermatitis	6.08e-05	0.000199	CcSEcCtD
Epirubicin—Myalgia—Triamcinolone—atopic dermatitis	6.07e-05	0.000198	CcSEcCtD
Epirubicin—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.06e-05	0.000198	CcSEcCtD
Epirubicin—Arthralgia—Methylprednisolone—atopic dermatitis	6.06e-05	0.000198	CcSEcCtD
Epirubicin—Myalgia—Methylprednisolone—atopic dermatitis	6.06e-05	0.000198	CcSEcCtD
Epirubicin—Eye disorder—Prednisone—atopic dermatitis	6.05e-05	0.000198	CcSEcCtD
Epirubicin—Anxiety—Methylprednisolone—atopic dermatitis	6.03e-05	0.000197	CcSEcCtD
Epirubicin—Tachycardia—Hydrocortisone—atopic dermatitis	6.03e-05	0.000197	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	6.01e-05	0.000197	CcSEcCtD
Epirubicin—Flushing—Prednisone—atopic dermatitis	6.01e-05	0.000196	CcSEcCtD
Epirubicin—Skin disorder—Hydrocortisone—atopic dermatitis	6e-05	0.000196	CcSEcCtD
Epirubicin—Ill-defined disorder—Dexamethasone—atopic dermatitis	6e-05	0.000196	CcSEcCtD
Epirubicin—Ill-defined disorder—Betamethasone—atopic dermatitis	6e-05	0.000196	CcSEcCtD
Epirubicin—Discomfort—Triamcinolone—atopic dermatitis	6e-05	0.000196	CcSEcCtD
Epirubicin—Discomfort—Methylprednisolone—atopic dermatitis	5.98e-05	0.000196	CcSEcCtD
Epirubicin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	5.97e-05	0.000195	CcSEcCtD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—KIF3A—atopic dermatitis	5.96e-05	0.0532	CbGpPWpGaD
Epirubicin—Dry mouth—Triamcinolone—atopic dermatitis	5.94e-05	0.000194	CcSEcCtD
Epirubicin—Anorexia—Hydrocortisone—atopic dermatitis	5.89e-05	0.000193	CcSEcCtD
Epirubicin—Nausea—Tacrolimus—atopic dermatitis	5.88e-05	0.000192	CcSEcCtD
Epirubicin—Angiopathy—Prednisone—atopic dermatitis	5.87e-05	0.000192	CcSEcCtD
Epirubicin—Confusional state—Methylprednisolone—atopic dermatitis	5.85e-05	0.000191	CcSEcCtD
Epirubicin—Immune system disorder—Prednisone—atopic dermatitis	5.84e-05	0.000191	CcSEcCtD
Epirubicin—Malaise—Betamethasone—atopic dermatitis	5.83e-05	0.000191	CcSEcCtD
Epirubicin—Malaise—Dexamethasone—atopic dermatitis	5.83e-05	0.000191	CcSEcCtD
Epirubicin—Anaphylactic shock—Triamcinolone—atopic dermatitis	5.82e-05	0.00019	CcSEcCtD
Epirubicin—Oedema—Triamcinolone—atopic dermatitis	5.82e-05	0.00019	CcSEcCtD
Epirubicin—Vertigo—Dexamethasone—atopic dermatitis	5.81e-05	0.00019	CcSEcCtD
Epirubicin—Vertigo—Betamethasone—atopic dermatitis	5.81e-05	0.00019	CcSEcCtD
Epirubicin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	5.8e-05	0.00019	CcSEcCtD
Epirubicin—Syncope—Dexamethasone—atopic dermatitis	5.8e-05	0.00019	CcSEcCtD
Epirubicin—Syncope—Betamethasone—atopic dermatitis	5.8e-05	0.00019	CcSEcCtD
Epirubicin—DHCR7—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	5.79e-05	0.0517	CbGpPWpGaD
Epirubicin—Arrhythmia—Prednisone—atopic dermatitis	5.78e-05	0.000189	CcSEcCtD
Epirubicin—Infection—Triamcinolone—atopic dermatitis	5.78e-05	0.000189	CcSEcCtD
Epirubicin—Hypotension—Hydrocortisone—atopic dermatitis	5.77e-05	0.000189	CcSEcCtD
Epirubicin—Infection—Methylprednisolone—atopic dermatitis	5.77e-05	0.000189	CcSEcCtD
Epirubicin—Shock—Triamcinolone—atopic dermatitis	5.72e-05	0.000187	CcSEcCtD
Epirubicin—Insomnia—Prednisolone—atopic dermatitis	5.72e-05	0.000187	CcSEcCtD
Epirubicin—Alopecia—Prednisone—atopic dermatitis	5.72e-05	0.000187	CcSEcCtD
Epirubicin—Shock—Methylprednisolone—atopic dermatitis	5.71e-05	0.000187	CcSEcCtD
Epirubicin—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.69e-05	0.000186	CcSEcCtD
Epirubicin—Loss of consciousness—Betamethasone—atopic dermatitis	5.68e-05	0.000186	CcSEcCtD
Epirubicin—Loss of consciousness—Dexamethasone—atopic dermatitis	5.68e-05	0.000186	CcSEcCtD
Epirubicin—Paraesthesia—Prednisolone—atopic dermatitis	5.68e-05	0.000186	CcSEcCtD
Epirubicin—Tachycardia—Triamcinolone—atopic dermatitis	5.68e-05	0.000186	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—atopic dermatitis	5.67e-05	0.000185	CcSEcCtD
Epirubicin—Tachycardia—Methylprednisolone—atopic dermatitis	5.67e-05	0.000185	CcSEcCtD
Epirubicin—Skin disorder—Methylprednisolone—atopic dermatitis	5.64e-05	0.000184	CcSEcCtD
Epirubicin—Erythema—Prednisone—atopic dermatitis	5.63e-05	0.000184	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—atopic dermatitis	5.63e-05	0.000184	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.63e-05	0.000184	CcSEcCtD
Epirubicin—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.62e-05	0.000184	CcSEcCtD
Epirubicin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.61e-05	0.000184	CcSEcCtD
Epirubicin—Convulsion—Betamethasone—atopic dermatitis	5.6e-05	0.000183	CcSEcCtD
Epirubicin—Convulsion—Dexamethasone—atopic dermatitis	5.6e-05	0.000183	CcSEcCtD
Epirubicin—Insomnia—Hydrocortisone—atopic dermatitis	5.59e-05	0.000183	CcSEcCtD
Epirubicin—Hypertension—Betamethasone—atopic dermatitis	5.58e-05	0.000183	CcSEcCtD
Epirubicin—Hypertension—Dexamethasone—atopic dermatitis	5.58e-05	0.000183	CcSEcCtD
Epirubicin—Paraesthesia—Hydrocortisone—atopic dermatitis	5.55e-05	0.000181	CcSEcCtD
Epirubicin—Myalgia—Betamethasone—atopic dermatitis	5.51e-05	0.00018	CcSEcCtD
Epirubicin—Myalgia—Dexamethasone—atopic dermatitis	5.51e-05	0.00018	CcSEcCtD
Epirubicin—Anxiety—Dexamethasone—atopic dermatitis	5.49e-05	0.000179	CcSEcCtD
Epirubicin—Anxiety—Betamethasone—atopic dermatitis	5.49e-05	0.000179	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—FCER1A—atopic dermatitis	5.45e-05	0.0487	CbGpPWpGaD
Epirubicin—Discomfort—Dexamethasone—atopic dermatitis	5.44e-05	0.000178	CcSEcCtD
Epirubicin—Discomfort—Betamethasone—atopic dermatitis	5.44e-05	0.000178	CcSEcCtD
Epirubicin—Dyspepsia—Hydrocortisone—atopic dermatitis	5.44e-05	0.000178	CcSEcCtD
Epirubicin—Hypotension—Methylprednisolone—atopic dermatitis	5.42e-05	0.000177	CcSEcCtD
Epirubicin—Pain—Prednisolone—atopic dermatitis	5.41e-05	0.000177	CcSEcCtD
Epirubicin—Decreased appetite—Hydrocortisone—atopic dermatitis	5.37e-05	0.000176	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.33e-05	0.000174	CcSEcCtD
Epirubicin—Fatigue—Hydrocortisone—atopic dermatitis	5.33e-05	0.000174	CcSEcCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—atopic dermatitis	5.31e-05	0.00881	CbGdCrCtD
Epirubicin—Vision blurred—Prednisone—atopic dermatitis	5.31e-05	0.000174	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.3e-05	0.000173	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.29e-05	0.000173	CcSEcCtD
Epirubicin—Pain—Hydrocortisone—atopic dermatitis	5.28e-05	0.000173	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—atopic dermatitis	5.28e-05	0.000173	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—atopic dermatitis	5.28e-05	0.000173	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—atopic dermatitis	5.28e-05	0.000173	CcSEcCtD
Epirubicin—Oedema—Betamethasone—atopic dermatitis	5.28e-05	0.000173	CcSEcCtD
Epirubicin—Insomnia—Triamcinolone—atopic dermatitis	5.26e-05	0.000172	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—atopic dermatitis	5.25e-05	0.000172	CcSEcCtD
Epirubicin—Infection—Betamethasone—atopic dermatitis	5.24e-05	0.000172	CcSEcCtD
Epirubicin—Infection—Dexamethasone—atopic dermatitis	5.24e-05	0.000172	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisone—atopic dermatitis	5.23e-05	0.000171	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—atopic dermatitis	5.22e-05	0.000171	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—atopic dermatitis	5.21e-05	0.000171	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—atopic dermatitis	5.21e-05	0.00017	CcSEcCtD
Epirubicin—Anaemia—Prednisone—atopic dermatitis	5.21e-05	0.00017	CcSEcCtD
Epirubicin—Shock—Dexamethasone—atopic dermatitis	5.19e-05	0.00017	CcSEcCtD
Epirubicin—Shock—Betamethasone—atopic dermatitis	5.19e-05	0.00017	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—atopic dermatitis	5.19e-05	0.00017	CcSEcCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—atopic dermatitis	5.18e-05	0.0086	CbGdCrCtD
Epirubicin—Nervous system disorder—Betamethasone—atopic dermatitis	5.18e-05	0.000169	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—atopic dermatitis	5.18e-05	0.000169	CcSEcCtD
Epirubicin—Agitation—Prednisone—atopic dermatitis	5.18e-05	0.000169	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—atopic dermatitis	5.17e-05	0.000169	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—atopic dermatitis	5.17e-05	0.000169	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—atopic dermatitis	5.15e-05	0.000168	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—atopic dermatitis	5.15e-05	0.000168	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—atopic dermatitis	5.12e-05	0.000167	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—atopic dermatitis	5.11e-05	0.000167	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.1e-05	0.000167	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—atopic dermatitis	5.1e-05	0.000167	CcSEcCtD
Epirubicin—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.09e-05	0.000167	CcSEcCtD
Epirubicin—Malaise—Prednisone—atopic dermatitis	5.08e-05	0.000166	CcSEcCtD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MS4A2—atopic dermatitis	5.06e-05	0.0453	CbGpPWpGaD
Epirubicin—Vertigo—Prednisone—atopic dermatitis	5.06e-05	0.000166	CcSEcCtD
Epirubicin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.05e-05	0.000165	CcSEcCtD
Epirubicin—Syncope—Prednisone—atopic dermatitis	5.05e-05	0.000165	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—atopic dermatitis	5.03e-05	0.000165	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—atopic dermatitis	5.03e-05	0.000165	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—atopic dermatitis	5.03e-05	0.000164	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—atopic dermatitis	5.02e-05	0.000164	CcSEcCtD
Epirubicin—Fatigue—Methylprednisolone—atopic dermatitis	5e-05	0.000164	CcSEcCtD
Epirubicin—Pain—Triamcinolone—atopic dermatitis	4.97e-05	0.000163	CcSEcCtD
Epirubicin—Loss of consciousness—Prednisone—atopic dermatitis	4.95e-05	0.000162	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—atopic dermatitis	4.93e-05	0.000161	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—atopic dermatitis	4.93e-05	0.000161	CcSEcCtD
Epirubicin—Urticaria—Hydrocortisone—atopic dermatitis	4.91e-05	0.000161	CcSEcCtD
Epirubicin—Abdominal pain—Hydrocortisone—atopic dermatitis	4.88e-05	0.00016	CcSEcCtD
Epirubicin—Body temperature increased—Hydrocortisone—atopic dermatitis	4.88e-05	0.00016	CcSEcCtD
Epirubicin—Convulsion—Prednisone—atopic dermatitis	4.88e-05	0.00016	CcSEcCtD
Epirubicin—Hypertension—Prednisone—atopic dermatitis	4.86e-05	0.000159	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	4.81e-05	0.000157	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	4.81e-05	0.000157	CcSEcCtD
Epirubicin—Myalgia—Prednisone—atopic dermatitis	4.8e-05	0.000157	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—atopic dermatitis	4.8e-05	0.000157	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—atopic dermatitis	4.79e-05	0.000157	CcSEcCtD
Epirubicin—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.78e-05	0.000156	CcSEcCtD
Epirubicin—Anxiety—Prednisone—atopic dermatitis	4.78e-05	0.000156	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—atopic dermatitis	4.77e-05	0.000156	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—atopic dermatitis	4.77e-05	0.000156	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	4.76e-05	0.000156	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.75e-05	0.000155	CcSEcCtD
Epirubicin—Paraesthesia—Dexamethasone—atopic dermatitis	4.74e-05	0.000155	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—atopic dermatitis	4.74e-05	0.000155	CcSEcCtD
Epirubicin—Discomfort—Prednisone—atopic dermatitis	4.74e-05	0.000155	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisolone—atopic dermatitis	4.66e-05	0.000152	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—atopic dermatitis	4.65e-05	0.000152	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—atopic dermatitis	4.65e-05	0.000152	CcSEcCtD
Epirubicin—AURKA—Aurora A signaling—NFKBIA—atopic dermatitis	4.63e-05	0.0413	CbGpPWpGaD
Epirubicin—Urticaria—Triamcinolone—atopic dermatitis	4.62e-05	0.000151	CcSEcCtD
Epirubicin—DHCR7—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	4.62e-05	0.0413	CbGpPWpGaD
Epirubicin—Urticaria—Methylprednisolone—atopic dermatitis	4.61e-05	0.000151	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—atopic dermatitis	4.6e-05	0.00015	CcSEcCtD
Epirubicin—Oedema—Prednisone—atopic dermatitis	4.6e-05	0.00015	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—atopic dermatitis	4.6e-05	0.00015	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—atopic dermatitis	4.59e-05	0.00015	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—atopic dermatitis	4.59e-05	0.00015	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—atopic dermatitis	4.59e-05	0.00015	CcSEcCtD
Epirubicin—Infection—Prednisone—atopic dermatitis	4.57e-05	0.000149	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.56e-05	0.000149	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.56e-05	0.000149	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.55e-05	0.000149	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—atopic dermatitis	4.55e-05	0.000149	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—atopic dermatitis	4.55e-05	0.000149	CcSEcCtD
Epirubicin—Shock—Prednisone—atopic dermatitis	4.52e-05	0.000148	CcSEcCtD
Epirubicin—Pain—Dexamethasone—atopic dermatitis	4.51e-05	0.000148	CcSEcCtD
Epirubicin—Pain—Betamethasone—atopic dermatitis	4.51e-05	0.000148	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—atopic dermatitis	4.51e-05	0.000147	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—atopic dermatitis	4.49e-05	0.000147	CcSEcCtD
Epirubicin—Skin disorder—Prednisone—atopic dermatitis	4.47e-05	0.000146	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—atopic dermatitis	4.44e-05	0.000145	CcSEcCtD
Epirubicin—Asthenia—Hydrocortisone—atopic dermatitis	4.43e-05	0.000145	CcSEcCtD
Epirubicin—Anorexia—Prednisone—atopic dermatitis	4.38e-05	0.000143	CcSEcCtD
Epirubicin—Pruritus—Hydrocortisone—atopic dermatitis	4.37e-05	0.000143	CcSEcCtD
Epirubicin—Feeling abnormal—Dexamethasone—atopic dermatitis	4.35e-05	0.000142	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—atopic dermatitis	4.35e-05	0.000142	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.32e-05	0.000141	CcSEcCtD
Epirubicin—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.32e-05	0.000141	CcSEcCtD
Epirubicin—Hypersensitivity—Triamcinolone—atopic dermatitis	4.29e-05	0.00014	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.28e-05	0.00014	CcSEcCtD
Epirubicin—Diarrhoea—Hydrocortisone—atopic dermatitis	4.23e-05	0.000138	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—atopic dermatitis	4.19e-05	0.000137	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—atopic dermatitis	4.19e-05	0.000137	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.19e-05	0.000137	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—atopic dermatitis	4.18e-05	0.000137	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—atopic dermatitis	4.17e-05	0.000137	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—atopic dermatitis	4.17e-05	0.000136	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—atopic dermatitis	4.17e-05	0.000136	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—atopic dermatitis	4.17e-05	0.000136	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—atopic dermatitis	4.17e-05	0.000136	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—atopic dermatitis	4.16e-05	0.000136	CcSEcCtD
Epirubicin—Insomnia—Prednisone—atopic dermatitis	4.16e-05	0.000136	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—atopic dermatitis	4.13e-05	0.000135	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—atopic dermatitis	4.12e-05	0.000135	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—atopic dermatitis	4.11e-05	0.000134	CcSEcCtD
Epirubicin—Dizziness—Hydrocortisone—atopic dermatitis	4.09e-05	0.000134	CcSEcCtD
Epirubicin—Dyspepsia—Prednisone—atopic dermatitis	4.05e-05	0.000132	CcSEcCtD
Epirubicin—TOP2A—Norethindrone—Hydrocortisone—atopic dermatitis	4.02e-05	0.00667	CbGdCrCtD
Epirubicin—Decreased appetite—Prednisone—atopic dermatitis	4e-05	0.000131	CcSEcCtD
Epirubicin—Rash—Prednisolone—atopic dermatitis	3.99e-05	0.00013	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—atopic dermatitis	3.99e-05	0.00013	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—atopic dermatitis	3.97e-05	0.00013	CcSEcCtD
Epirubicin—Fatigue—Prednisone—atopic dermatitis	3.96e-05	0.00013	CcSEcCtD
Epirubicin—Headache—Prednisolone—atopic dermatitis	3.96e-05	0.00013	CcSEcCtD
Epirubicin—Constipation—Prednisone—atopic dermatitis	3.93e-05	0.000129	CcSEcCtD
Epirubicin—Vomiting—Hydrocortisone—atopic dermatitis	3.93e-05	0.000128	CcSEcCtD
Epirubicin—Rash—Hydrocortisone—atopic dermatitis	3.9e-05	0.000127	CcSEcCtD
Epirubicin—Dermatitis—Hydrocortisone—atopic dermatitis	3.89e-05	0.000127	CcSEcCtD
Epirubicin—Headache—Hydrocortisone—atopic dermatitis	3.87e-05	0.000127	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—atopic dermatitis	3.85e-05	0.000126	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—atopic dermatitis	3.84e-05	0.000126	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisone—atopic dermatitis	3.79e-05	0.000124	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—atopic dermatitis	3.79e-05	0.000124	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—atopic dermatitis	3.79e-05	0.000124	CcSEcCtD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NGF—atopic dermatitis	3.77e-05	0.0337	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Prednisone—atopic dermatitis	3.76e-05	0.000123	CcSEcCtD
Epirubicin—Nausea—Prednisolone—atopic dermatitis	3.76e-05	0.000123	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—atopic dermatitis	3.73e-05	0.000122	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—atopic dermatitis	3.73e-05	0.000122	CcSEcCtD
Epirubicin—Vomiting—Triamcinolone—atopic dermatitis	3.7e-05	0.000121	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—atopic dermatitis	3.69e-05	0.000121	CcSEcCtD
Epirubicin—Nausea—Hydrocortisone—atopic dermatitis	3.67e-05	0.00012	CcSEcCtD
Epirubicin—Rash—Triamcinolone—atopic dermatitis	3.67e-05	0.00012	CcSEcCtD
Epirubicin—Dermatitis—Triamcinolone—atopic dermatitis	3.66e-05	0.00012	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—atopic dermatitis	3.66e-05	0.00012	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—atopic dermatitis	3.66e-05	0.00012	CcSEcCtD
Epirubicin—Urticaria—Prednisone—atopic dermatitis	3.65e-05	0.000119	CcSEcCtD
Epirubicin—Headache—Triamcinolone—atopic dermatitis	3.64e-05	0.000119	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—atopic dermatitis	3.64e-05	0.000119	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—atopic dermatitis	3.63e-05	0.000119	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—atopic dermatitis	3.63e-05	0.000119	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—atopic dermatitis	3.61e-05	0.000118	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—atopic dermatitis	3.61e-05	0.000118	CcSEcCtD
Epirubicin—Dizziness—Betamethasone—atopic dermatitis	3.49e-05	0.000114	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—atopic dermatitis	3.49e-05	0.000114	CcSEcCtD
Epirubicin—Nausea—Triamcinolone—atopic dermatitis	3.46e-05	0.000113	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—atopic dermatitis	3.45e-05	0.000113	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisone—atopic dermatitis	3.39e-05	0.000111	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—atopic dermatitis	3.36e-05	0.00011	CcSEcCtD
Epirubicin—Vomiting—Dexamethasone—atopic dermatitis	3.36e-05	0.00011	CcSEcCtD
Epirubicin—Rash—Betamethasone—atopic dermatitis	3.33e-05	0.000109	CcSEcCtD
Epirubicin—Rash—Dexamethasone—atopic dermatitis	3.33e-05	0.000109	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—atopic dermatitis	3.33e-05	0.000109	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—atopic dermatitis	3.33e-05	0.000109	CcSEcCtD
Epirubicin—Headache—Betamethasone—atopic dermatitis	3.31e-05	0.000108	CcSEcCtD
Epirubicin—Headache—Dexamethasone—atopic dermatitis	3.31e-05	0.000108	CcSEcCtD
Epirubicin—Asthenia—Prednisone—atopic dermatitis	3.3e-05	0.000108	CcSEcCtD
Epirubicin—Pruritus—Prednisone—atopic dermatitis	3.25e-05	0.000106	CcSEcCtD
Epirubicin—TOP2A—Levonorgestrel—Hydrocortisone—atopic dermatitis	3.2e-05	0.0053	CbGdCrCtD
Epirubicin—Diarrhoea—Prednisone—atopic dermatitis	3.15e-05	0.000103	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—atopic dermatitis	3.14e-05	0.000103	CcSEcCtD
Epirubicin—Nausea—Betamethasone—atopic dermatitis	3.14e-05	0.000103	CcSEcCtD
Epirubicin—Dizziness—Prednisone—atopic dermatitis	3.04e-05	9.94e-05	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—RELB—atopic dermatitis	2.97e-05	0.0266	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—atopic dermatitis	2.92e-05	9.56e-05	CcSEcCtD
Epirubicin—Rash—Prednisone—atopic dermatitis	2.9e-05	9.48e-05	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—atopic dermatitis	2.9e-05	9.47e-05	CcSEcCtD
Epirubicin—Headache—Prednisone—atopic dermatitis	2.88e-05	9.42e-05	CcSEcCtD
Epirubicin—Nausea—Prednisone—atopic dermatitis	2.73e-05	8.93e-05	CcSEcCtD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP8—atopic dermatitis	2.69e-05	0.024	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—MAPK8—atopic dermatitis	2.61e-05	0.0233	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—KIF3A—atopic dermatitis	2.4e-05	0.0214	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.13e-05	0.019	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL13—atopic dermatitis	2.01e-05	0.0179	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—MAPK8—atopic dermatitis	1.87e-05	0.0167	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	1.85e-05	0.0165	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—NFKBIA—atopic dermatitis	1.77e-05	0.0158	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—MAPK8—atopic dermatitis	1.52e-05	0.0136	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MAPK8—atopic dermatitis	1.41e-05	0.0126	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	1.31e-05	0.0117	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—atopic dermatitis	1.26e-05	0.0112	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	1.18e-05	0.0105	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—atopic dermatitis	1.17e-05	0.0105	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NGF—atopic dermatitis	1.17e-05	0.0104	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NFKBIA—atopic dermatitis	1.16e-05	0.0104	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—MAPK8—atopic dermatitis	1.11e-05	0.00991	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NPS—atopic dermatitis	1.05e-05	0.00942	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CASP8—atopic dermatitis	1.05e-05	0.00935	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	1e-05	0.00894	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GLB1—atopic dermatitis	9.49e-06	0.00848	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ADSL—atopic dermatitis	9.1e-06	0.00813	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CASP8—atopic dermatitis	8.73e-06	0.0078	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—MAPK8—atopic dermatitis	8.29e-06	0.00741	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	7.87e-06	0.00703	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	7.82e-06	0.00699	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MAPK8—atopic dermatitis	7.75e-06	0.00693	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	7.73e-06	0.00691	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MAPK8—atopic dermatitis	7.56e-06	0.00675	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MAPK8—atopic dermatitis	7.28e-06	0.0065	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.22e-06	0.00645	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	7.21e-06	0.00644	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.92e-06	0.00618	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.86e-06	0.00613	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	6.78e-06	0.00605	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KIF3A—atopic dermatitis	6.64e-06	0.00594	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	6.62e-06	0.00591	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	6.58e-06	0.00588	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—PPARA—atopic dermatitis	6.22e-06	0.00555	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—MAPK8—atopic dermatitis	6.07e-06	0.00542	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.77e-06	0.00515	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	5.72e-06	0.00512	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SELE—atopic dermatitis	5.35e-06	0.00478	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL22—atopic dermatitis	5.35e-06	0.00478	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.16e-06	0.00461	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	4.96e-06	0.00443	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—atopic dermatitis	4.8e-06	0.00429	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.78e-06	0.00427	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL27—atopic dermatitis	4.77e-06	0.00426	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	4.47e-06	0.004	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	4.37e-06	0.0039	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL17—atopic dermatitis	4.28e-06	0.00382	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL5—atopic dermatitis	4.06e-06	0.00363	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	3.88e-06	0.00346	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.86e-06	0.00345	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.67e-06	0.00328	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.59e-06	0.00321	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—MAPK8—atopic dermatitis	3.45e-06	0.00308	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL11—atopic dermatitis	3.45e-06	0.00308	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FCER2—atopic dermatitis	3.4e-06	0.00304	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GLB1—atopic dermatitis	3.28e-06	0.00293	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GLB1—atopic dermatitis	3.21e-06	0.00287	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL22—atopic dermatitis	3.16e-06	0.00282	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADSL—atopic dermatitis	3.14e-06	0.00281	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.11e-06	0.00278	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPARA—atopic dermatitis	3.08e-06	0.00275	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADSL—atopic dermatitis	3.08e-06	0.00275	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GLB1—atopic dermatitis	3.07e-06	0.00274	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.01e-06	0.00269	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.84e-06	0.00254	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL27—atopic dermatitis	2.82e-06	0.00252	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR3—atopic dermatitis	2.81e-06	0.00251	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GLB1—atopic dermatitis	2.57e-06	0.00229	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL17—atopic dermatitis	2.53e-06	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TAC1—atopic dermatitis	2.5e-06	0.00224	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NPS—atopic dermatitis	2.5e-06	0.00224	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADSL—atopic dermatitis	2.46e-06	0.0022	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	2.46e-06	0.0022	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR3—atopic dermatitis	2.46e-06	0.00219	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.34e-06	0.00209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL5—atopic dermatitis	2.33e-06	0.00208	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIF3A—atopic dermatitis	2.25e-06	0.00201	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—atopic dermatitis	2.2e-06	0.00197	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC11A1—atopic dermatitis	2.05e-06	0.00184	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL11—atopic dermatitis	2.04e-06	0.00182	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CMA1—atopic dermatitis	2.04e-06	0.00182	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL10—atopic dermatitis	1.99e-06	0.00177	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT6—atopic dermatitis	1.91e-06	0.00171	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.87e-06	0.00167	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.78e-06	0.00159	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL5—atopic dermatitis	1.71e-06	0.00153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR3—atopic dermatitis	1.66e-06	0.00148	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—atopic dermatitis	1.55e-06	0.00139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—atopic dermatitis	1.54e-06	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NPS—atopic dermatitis	1.48e-06	0.00132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TAC1—atopic dermatitis	1.48e-06	0.00132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR3—atopic dermatitis	1.45e-06	0.0013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL5—atopic dermatitis	1.38e-06	0.00123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—atopic dermatitis	1.17e-06	0.00105	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARA—atopic dermatitis	1.06e-06	0.00095	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARA—atopic dermatitis	1.04e-06	0.000932	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—atopic dermatitis	1.04e-06	0.000927	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—atopic dermatitis	1.01e-06	0.000902	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NGF—atopic dermatitis	9.35e-07	0.000836	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—atopic dermatitis	9.31e-07	0.000832	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—atopic dermatitis	9.1e-07	0.000813	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—atopic dermatitis	8.9e-07	0.000795	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARA—atopic dermatitis	8.33e-07	0.000745	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKBIA—atopic dermatitis	7.71e-07	0.000689	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—atopic dermatitis	6.52e-07	0.000582	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—atopic dermatitis	5.5e-07	0.000491	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—atopic dermatitis	5.26e-07	0.00047	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—atopic dermatitis	5.23e-07	0.000467	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—atopic dermatitis	4.84e-07	0.000432	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—atopic dermatitis	3.52e-07	0.000315	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—atopic dermatitis	3.09e-07	0.000276	CbGpPWpGaD
